OTOA: A Potential Drug Target for Cancer and Testicular Tumors

Target Name: OTOA

NCBI ID: G146183

OTOA

OTOA: A Potential Drug Target for Cancer and Testicular Tumors

OTOA (Cancer/testis antigen 108) is a protein that is expressed in various tissues throughout the body, including the skin, hair, and lymphoid organs. It is also a potent cancer and testis antigen, which means that it can be used as a marker for cancer and testicular tumors.

The discovery of OTOA as a potential drug target or biomarker has significant implications for the treatment of cancer. OTOA has been shown to be highly expressed in a variety of cancer types, including breast, ovarian, and prostate cancers. Additionally, studies have shown that OTOA has been associated with poor prognosis in patients with these cancers.

OTOA is also a good candidate as a biomarker for cancer, as it can be easily detected and measured in different types of cancer. This makes it an attractive tool for the development of new diagnostic tests for cancer.

In addition to its potential as a drug target or biomarker, OTOA also has important functions in the immune system. It is a key regulator of the immune response, and it has been shown to play a role in the regulation of inflammation and immune cell function.

The identification of OTOA as a potential drug target has led to a great deal of interest and research in this area. Many researchers are now working to develop small molecules and other compounds that can inhibit OTOA's activity and prevent it from being used as a cancer or testis antigen.

In addition to its potential as a drug target, OTOA also has important implications for the study of cancer biology. OTOA has been shown to be involved in the regulation of cell growth, cell division, and apoptosis (programmed cell death). This makes it an important target for researchers who are studying the causes and consequences of cancer.

Overall, OTOA is a protein that has significant potential as a drug target or biomarker for cancer. Its high expression in various tissues and its association with cancer make it an attractive target for researchers who are working to develop new treatments for this disease. Additionally, OTOA's role in the immune system and its involvement in the regulation of cell growth and apoptosis make it an important molecule to study in the context of cancer biology.

Protein Name: Otoancorin

Functions: May act as an adhesion molecule

The "OTOA Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OTOA comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets